Non-Invasive Methods for Diagnosis and Progression of Diabetes, Kidney, Urological, Hematological And Digestive Diseases (R21)

The summary for the Non-Invasive Methods for Diagnosis and Progression of Diabetes, Kidney, Urological, Hematological And Digestive Diseases (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Non-Invasive Methods for Diagnosis and Progression of Diabetes, Kidney, Urological, Hematological And Digestive Diseases (R21): This funding opportunity announcement (FOA) is a call for the application of imaging and other non- or minimally-invasive technologies to detect, characterize, diagnose, identify persons with predisposition to, or monitor treatment of diseases of interest to the National Institute of Diabetes and Digestive and Kidney Diseases. Also needed are new, robust surrogate markers for clinical trial endpoints, and new ways to characterize normal and pathological tissues in vivo. Diseases of interest include type 1 and 2 diabetes, obesity, and kidney, liver, urologic, hematologic, digestive, endocrine and metabolic diseases and their complications. Applicable techniques include molecular imaging and functional imaging approaches, imaging methods with high spatial, chemical or time resolution, and new spectroscopic or sensor array technologies for monitoring metabolic or physiological events. -This funding opportunity will utilize the Exploratory/Developmental (R21) grant mechanism, but will be run in parallel with a funding opportunity of identical scientific scope (PA-06-143) that will utilize the traditional research project grant (R01). -Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. -The total project period for an application submitted in response to this funding opportunity may not exceed two years. Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year. -Eligible organizations: For profit organizations; Non-profit organizations; Public or private institutions, such as universities, colleges, hospitals and laboratories; Units of State government; Units of local government; Eligible institutions of the Federal government; Domestic institutions; and Foreign institutions. -Eligible Project Directors/Principal Investigators (PD/PIs): Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH programs. -Applicants may submit more than one application, provided each application is scientifically distinct.
Federal Grant Title: Non-Invasive Methods for Diagnosis and Progression of Diabetes, Kidney, Urological, Hematological And Digestive Diseases (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Health Food and Nutrition
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-06-142
Type of Funding: Grant
CFDA Numbers: 93.84793.848
CFDA Descriptions: Diabetes, Endocrinology and Metabolism Research 93.848 Digestive Diseases and Nutrition Research
Current Application Deadline: No deadline provided
Original Application Deadline: May 02, 2009
Posted Date: Mar 02, 2006
Creation Date: Nov 09, 2006
Archive Date: Dec 15, 2006
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.849 -- Kidney Diseases, Urology and Hematology Research
Applicants Eligible for this Grant
Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Public and State controlled institutions of higher education Special district governments For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) State governments Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected] [email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster